Aigh Capital Management LLC Abeona Therapeutics Inc. Transaction History

Aigh Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$3.71 - $5.14 $1.29 Million - $1.79 Million	-347,483 Reduced 30.61%	787,769 $3.95 Million
Q3 2023 Nov 13, 2023	BUY	$2.98 - $4.43 $1.48 Million - $2.2 Million	496,278 Added 77.67%	1,135,252 $4.78 Million
Q2 2023 Aug 14, 2023	SELL	$2.76 - $5.27 $36,432 - $69,564	-13,200 Reduced 2.02%	638,974 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$2.4 - $4.39 $1.23 Million - $2.25 Million	511,530 Added 363.71%	652,174 $2.01 Million
Q3 2022 Nov 10, 2022	BUY	$3.03 - $5.56 $426,151 - $781,980	140,644 New	140,644 $428,000

14.4M

715K

58K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $25.1M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.